5 hours Legend Biotech’s J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma Investor's Business Daily
Legend Biotech said Friday its cancer drug, Carvykti, lowered the risk of death by 45% in a study of multiple myeloma patients.
The post Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma appeared first on In…
Biotech · Johnson & Johnson (JNJ)